Management of Pulmonary Infections in Kidney Transplant Patients

Clinical Pulmonary Medicine

Volumn 10, Issue 6, 2003, Pages 308-321

  Aranha Camargo, Luis Fernando ^a,b,d   Souza Gomes, Pollyane ^a   Pinheiro Machado, Paula Goulart ^c   Medina Pestana, José Osmar ^c  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^b HOSPITAL ISRAELITA ALBERT EINSTEIN   (Brazil)

^c HOSPITAL DO RIM E HIPERTENSÃO   (Brazil)

^d Transplantation Unit ^*  (Brazil)

Author keywords

Diagnosis; Kidney transplant; Pulmonary infections; Treatment

Indexed keywords

ALBENDAZOLE; AMPHOTERICIN B; CEPHALOSPORIN; COTRIMOXAZOLE; CYCLOSPORIN; FLUCONAZOLE; GANCICLOVIR; ISONIAZID; ITRACONAZOLE; IVERMECTIN; LYMPHOCYTE ANTIBODY; MACROLIDE; METHYLPREDNISOLONE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; RIFAMPICIN; TACROLIMUS; VORICONAZOLE;

ANTIBIOTIC PROPHYLAXIS; ANTIMICROBIAL THERAPY; BRONCHOSCOPY; CARDIOVASCULAR DISEASE; CAUSE OF DEATH; CYTOMEGALOVIRUS; DIAGNOSTIC APPROACH ROUTE; DISEASE SEVERITY; FUNGUS; HUMAN; INFECTION PREVENTION; INTERMETHOD COMPARISON; KIDNEY FAILURE; KIDNEY TRANSPLANTATION; LEGIONELLA; LUNG INFECTION; LUNG LAVAGE; MORTALITY; NONHUMAN; OPEN LUNG BIOPSY; PNEUMOCYSTIS CARINII; POSTOPERATIVE COMPLICATION; QUALITY OF LIFE; RESPIRATORY FAILURE; REVIEW; SIDE EFFECT; SURVIVAL;

EID: 1542284606     PISSN: 10680640     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.cpm.0000087521.52559.69     Document Type: Review

References (115)

1. Medina-Pestana JO, Vaz ML, Park SI, Organ transplant in Brazil. Transpl Proc, 2002;34(2):441-443.
2. Laupacis A, Keown P, Pus N, et al. A study of the quality of life and cost-utility of renal transplantation. Kidney Int. 1996;50:235-242.
3. Jofre R, Lopez-Gomez JM, Moreno F, et al. Changes in quality of life after renal transplantation. Am J Kidney Dis. 1998;32:93-100.
4. Simmons RG, Abress L. Quality of life issues for end-stage renal disease patients. Am J Kidney Dis. 1990;15:201-208.
5. Whiting JF, Zavala EY, Alexander JW, et al. The cost-effectiveness of transplantation with expanded donor kidneys. Transplant Proc. 1999;31:1320-1321.
6. Ojo AO, Hanson JA, Meier Kriesche H, et al. Survival in recipients of marginal cadaveric donor kidneys compared with other recipients and wait-listed transplant candidates. J Am Soc Nephrol. 2001;12:589-597.
7. Wolfe RA, Ashby VB, Milford EL, et al. Comparison of mortality in all patients on dialysis, patients on dialysis, patients on dialysis awaiting transplantation, and recipients of a first cadaveric transplant. N Engl J Med. 1999;341:1725-1730.
8. Pascual M, Theruvath T, Kawai T, et al. Strategies to improve long-term outcomes after renal transplantation. N Engl J Med. 2002;346:580-590.
9. Rubin RH, Ikonen T, Gummer JF, et al. The therapeutic prescription for the organ transplant recipient: the linkage of immunosuppression and antimicrobial strategies. Transplant Infect Dis. 1999;1:29-39.
10. Nashan B, Luck R, Kliem V, et al. CMV in kidney transplantation: a single center experience over 22 years. Clin Transplant. 1999;181-188.
11. Jamil B, Nicholls KM, Becker GL, et al. Influence of anti-rejection therapy on the timing of cytomegalovirus disease and other infections in renal transplant recipients. Clin Transplant. 2000;14:14-18.
12. Gallagher H, Andrews PA. Cytomegalovirus infection and abdominal pain with mycophenolate mofetil: is there a link? Drug Saf. 2001;24:405-412.
13. Ter Meulen CG, Wetzels JF, Hilbrands LB. The influence of mycophenolate mofetil on the incidence and severity of primary cytomegalovirus infections and disease after renal transplantation. Nephrol Dial Transplant. 2000;15:711-714.
14. Kubak BM, Pegues DA, Holt CD, et al. Changing patterns of fungal infection in transplantation. Curr Opin Organ Transplantation. 2000;5:176-191.
15. Abbott KC, Hypolite I, Poropatich RK, et al. Hospitalizations for fungal infections after renal transplantation in the United States. Transplant Inf Dis. 2001;3:203-211.
16. Rubin RH. Infection in the organ transplant recipient. In: Rubin RH, Young LS, eds. Clinical Approach to Infection in the Compromised Host3rd ed. New York: Plenum Publishing 1994:629-705.
17. Fishman JA, Rubin RH. Infection in organ transplant recipients. N Engl J Med. 1998;338:1741-1751.
18. Ettinger NA. Solid organ and bone marrow transplantation: clinical approach to upper and lower respiratory infections. In: Neiderman MS, Sarosi GA, Glassroth J, eds. Respiratory Infections: A Scientific Basis for Management. Philadelphia: WB Saunders; 1994.
19. Nusair S, Kramer MR. The role of fiber-optic bronchoscopy in solid organ, transplant patients with pulmonary infections. Respir Med. 1999;93:621-629.
20. Heurlin N, Brattström C, Tydén G, et al. Cytomegalovirus the predominant cause of pneumonia in renal transplant patients. Scand J Infect Dis. 1989;21:245-253.
21. Waltzer WC, Sterioff S, Zincke H, et al. Open-lung biopsy in the renal transplant recipient. Surgery 1980;88:601-609.
22. Sternberg RI, Baughman RP, Dohn MN, et al. Utility of bronchoalveolar lavage in assessing pneumonia in immunosuppressed renal transplant recipients. Am J Med. 1993;95:358-364.
23. Benedetti E, Sileri P, Pursell KJ, et al. Treatment of severe pneumonia in kidney transplant recipients. Transplantation Proceedings. 2001;33:3652.
24. Dowling JN, Pasculle AW, Frola FN, et al. Infections caused by Legionella micdadei and Legionella pneumophila among renal transplant recipients. J Infect Dis. 1984;149:703-713.
25. Stout JE, Yu VL, Best M. Ecology of Legionella pneumophila within water distribution system. Appl Environ Microbiol. 1985;49:221-228.
26. Muder RR, Yu VL, Woo A. Mode of transmission of Legionella pneumophila: a critical review. Arch Intern Med. 1986;146:1607-1612.
27. Levin ASS, Caiaffa Filho HH, Sinto SI, et al. An outbreak of nosocomial Legionnaires' disease in a renal transplant unit in São Paulo, Brazil. Hosp Infect. 1991;18:243-248.
28. Bock BV, Kirby BD, Edelstein PH, et al. Legionnaires' disease in renal-transplant recipients. Lancet. 1978;1:410-413.
29. Gomberg ME, Josephson A, Goldstein EJC, et al. Cavitary Legionnaire's pneumonia: nosocomial infection in renal transplant recipients. Am J Surg. 1984;147:402-405.
30. Wilczek H, Kallings I, Nystrom B, et al. Nosocomial Legionnaires' disease in renal transplantation. Transplantation. 1987;43:847-851.
31. Kirby DB, Peck H, Meyer RD. Radiographic features of Legionnaires' disease. Chest. 1979;76:562-565.
32. Bauling PC, Weil RI, Schöter GPJ. Legionella lung abscess after renal transplantation. J Infect, 1985;11:51-55.
33. Broome CV, Cherry WB, Winn WC, et al. Rapid diagnosis of Legionnaires' disease by direct immunofluorescent staining. Ann Intern Med. 1979;90:1-4.
34. Edelstein PH, Meyer RD, Finegold SM. Laboratory diagnosis of Legionnaires' disease. Am Rev Respir Dis. 1980;121:317-327.
35. Kohler RB, Winn WC, Wheat LJ. Onset and duration of urinary antigen excretion in Legionnaires' disease. J Clin Microbiol. 1984;20:605-607.
36. Ruf B, Schürmann D, Horbach I, et al. Prevalence and diagnosis of Legionella pneumonia: a 3-year prospective study with emphasis on application of urinary antigen detection. J Infect Dis. 1990;162:1341-1348.
37. Johnson DM, Erwin ME, Barrett MS, et al. Antimicrobial activity of ten macrolide, lincosamine and streptogramin drugs tested against Legionella species. Eur J Clin Microbiol Infect Dis. 1992;11:751-755.
38. Hamedani P, Ali J, Hafeez S, et al. The safety and efficacy of clarithromycin in patients with Legionella pneumonia. Chest. 1991;100:1503-1506.
39. Davis CL. The prevention of cytomegalovirus disease in renal transplantation. Am J Kidney Dis. 1990;16:175-188.
40. Hedemark LL, Kronenberg RS, Rasp FL, et al. The value of bronchoscopy in establishing the etiology of pneumonia in renal transplant recipients. Am Rev Respir Dis. 1982;126:981-985.
41. Reichenberger F, Dickenmann M, Binet I, et al. Diagnostic yield of bronchoalveolar lavage following renal transplantation. Transplant Infect Dis. 2001;3:2-8.
42. Leung Ann N, Gosselin MV, Napper CH, et al. Pulmonary Infections after bone marrow transplantation: clinical and radiographic findings. Radiology. 1999;210:699-709.
43. Enright H, Haake R, Weisdorf D, et al. Cytomegalovirus pneumonia after bone marrow transplantation: risk factors and response to therapy. Transplantation. 1993;55:1339-1346.
44. Wilczek B, Wilczek HE, Heurlin N, et al. Prognostic significance of pathologic chest radiography in transplant patients affected by cytomegalovirus and/or Pneumocystis carinii. Acta Radiol. 1996;37:727-731.
45. Ruutu P, Ruutu T, Volin L, et al. Cytomegalovirus is frequently isolated in bronchoalveolar lavage fluid of bone marrow transplant recipients without pneumonia. Ann Intern Med. 1990;112:913-916.
46. Crawford SW, Bowden RA, Hackman RC, et al. Rapid detection of Cytomegalovirus pulmonary infection by bronchoalveolar lavage and centrifuge culture. Ann Int Med. 1998;108:180-185.
47. Beaman BL, Beaman I. Nocardial species, host-parasite relationship. Clin Micro Rev. 1994;7:213-264.
48. Wilson JP, Turner HR, Kirchner KA, et al. Nocardial infections in renal transplant recipients. Medicine. 1989;68:38-57.
49. Arduino RC, Johnson PC, Miranda AG. Nocardiosis in renal transplant recipients undergoing immunossupression with cyclosporine. Clin Infect Dis. 1993;16:505-512.
50. Chapman SW, Wilson JP. Nocardiosis in transplant recipients. Semin Respir Infect. 1990;5:74-79.
51. McNeil MM, Brown JM, Hutwagner LC, et al. Evaluation of therapy for Nocardia aseroides complex infections. Infect Dis Clin Pract. 1995;4:287-292.
52. Chaves J, David S, Wauters J, et al. Transmission of Pneumocystis carinii from AIDS patients to other immunosuppressed patients: a cluster of Pneumocystis carinii pneumonia in renal transplant recipients. AIDS. 1991;5:927-932.
53. Rubin RH. Infectious disease complications of renal transplantation. Kidney Int. 1993;44:221.
54. Sugimoto A, Uchida H, Akiyama N, et al. Improved survival of renal allograft recipients with Pneumocystis carinii pneumonia by early diagnosis and treatment. Transplant Proc. 1992;24:1556.
55. Talseth T, Holdaas H, Albrechtsen D, et al. Increasing incidence of Pneumocystis carinii pneumonia in renal transplant patients. Transplant Proc. 1988;20:400.
56. Santiago-Delfin EA, Mora E, Gonzales ZA, et al. Factors in an outbreak of Pneumocystis carinii in a transplant unit. Transplant Proc, 1988;20(suppl 1):462.
57. Branten AJW, Beckers PJ, Tiggeler RGW, et al. Pneumocystis carinii pneumonia in renal transplant recipients. Nephrol Dial Transplant. 1995;10:1194.
58. Lufft V, Kliem V, Behrend M, et al. Incidence of Pneumocystis carinii pneumonia after renal transplantation. Transplantation. 1996;62:421-423.
59. Meduri GU, Stover DE, Geeno RA, et al. Bilateral bronchoalveolar lavage in the diagnosis of opportunistic pulmonary infections. Chest. 1991;100:1272-1276.
60. Stover DE, Zaman MB, Hajdu SI, et al. Bronchoalveolar lavage in the diagnosis of diffuse pulmonary infiltrates in the immunosuppressed host. Ann Intern Med. 1984;101:1-7.
61. Schulman LL, Reison DS, Austin JHM, et al. Cytomegalovirus pneumonitis after cardiac transplantation. Arch Intern Med. 1991;151:1118-1124.
62. Barnes PF, Barrows AS. Tuberculosis in the 1990s. Ann Intern Med. 1993;119:400-410.
63. Biz E, Pereira CAP, Moura LAB, et al. The use of cyclosporine modifies the clinical and histopathological presentation of tuberculosis afier after renal transplantation. Revista Instituto Med Tropical São Paulo. 2000;42:225-230.
64. Aguado JM, Herrero JA, Gavalda J, et al. Clinical presentation and outcome of tuberculosis in kidney, liver, and heart transplant recipients in Spain. Spanish Transplantation Infection Study Group, GESITRA. Transplantation. 1997;63:1278-1286.
65. Patel R, Roberts GD, Keating MR, et al. Infections due to nontuberculous mycobacteria in kidney, heart, and liver transplant recipients. Clin Infect Dis. 1994;19:263-273.
66. Munoz P, Palomo J, Rodriguez-Creixems M. Tuberculosis in heart transplant recipients. Clin Infect Dis. 1995;21:398-402.
67. Delaney V, Sumrani N, Hong JH, et al. Mycobacterial infections in renal allograft recipients. Transplant Proc. 1993;25:2288-2289.
68. Malhotra KK, Dash SC, Dhawan IK, et al. Tuberculosis and renal transplantation: observations from an endemic area of tuberculosis. Postgrad Med J. 1986;62:359-362.
69. Sakhuja V, Jha V, Verma PP, et al. The high incidence of tuberculosis among renal transplant recipients in India. Transplantation. 1996;61:211-215.
70. Mourad G, Soulillou JP, Chong G, et al. Transmission of Mycobacterium tuberculosis with renal allografts. Nephron. 1985;41:82-85.
71. Higgins RM, Cahn AP, Porter D, et al. Mycobacterial infection after renal transplantation. Q J Med. 1991;286:145-153.
72. Apaydin S, Altiparmak MR, Serdengeçti K, et al. Mycobacterium tuberculosis infections after renal transplantation. Scand J Infect Dis. 2000;32:501-505.
73. John GT, Thomas PP, Thomas M, et al. A double-blind randomized controlled trials of primary isoniazid prophylaxis in dialysis and transplant patients. Transplantation. 1994;87:1683-1684.
74. Denning DW, Stevens DA. Antifungical and surgical treatment of invasive aspergillosis: a review of 2121 published cases. Rev Infect Dis. 1990;12:1147-1201.
75. Rinaldi MG. Invasive aspergillosis. Rev Infect Dis. 1983;5:1061-1077.
76. Cohen J. Clinical manifestation and management of aspergillosis in the compromised patient. In: Warnock DW, Richardson MD, eds. Fungal Infection in the Compromised Patient, 2nd ed. New York: John Wiley; 1991:118-152.
77. Dummer JS, Hardy A, Poorsatter A, et al. Early infections in kidney, heart, and liver transplant recipients on cyclosporine. Transplantation. 1983;36:259-267.
78. Masur H, Cheigh JS, Stubenbord WT. Infection following renal transplantation: a changing pattern. Rev Infect Dis. 1982;4:1208-1219.
79. Young RC, Bennet JE, Vogel CL, et al. Aspergillosis: the spectrum of the disease in 98 patients. Medicine. 1970;49:147-173.
80. Zeluff JZ. Fungal pneumonia in transplant recipients. Semin Respir Infect. 1990;1:80-89.
81. Gallis HA, Berman RA, Cate TR, et al. Fungal infections following renal transplantation. Arch Intern Med. 1975;135:1163-1172.
82. Weiland D, Fergunson RM, Peterson PK, et al. Aspergillosis in 25 renal transplant patients: epidemiology, clinical presentation, diagnosis and management. Ann Surg. 1983;198:622-629.
83. Koselj-Kajtna M, Kandus A, Rott T, et al. Aspergillus infection in immunocompromised patients. Transplant Proc. 2001;33:2176-2178.
84. Westney GE, Kesten S, de Hoyos A, et al. Aspergillus infection in single and double lung transplant recipients. Transplantation. 1996;61:915-919.
85. Pasmans HLM, Loosveld OJL, Schouten HC, et al. Invasive aspergillosis in immunocompromised patients: findings on plain film and CT. Eur J Radiol. 1992;14:37-40.
86. Staples CA, Kang EY, Wright JL, et al. Invasive pulmonary aspergillosis in AIDS: radiographic, CT, and pathologic findings. Radiology. 1995;196:409-414.
87. Hadley S, Karchmer AW. Fungal infections in solid organ transplant recipients. Infect Dis Clin North Am. 1995;4:1045-1074.
88. Mora NP, Klintmalm G, Solomon RM, et al. Selective amphotericin B prophylaxis in the reduction of fungal infections after liver transplant. Transplant Proc. 1993;24:154-155.
89. Armstrong D. Treatment of opportunistic fungal infections. Clin Infect Dis. 1993;16:1-7.
90. Denning DW, Lee JY, Hostetler JS, et al. NIAID Mycoses Study Group Multicenter trial of oral itraconazole therapy of invasive aspergillosis. Am J Med. 1994;97:135-144.
91. Husain S, Wagener MM, Singh N. Cryptococcus neoformans infection in organ transplant recipients: variables influencing clinical characteristics and outcome. Emerg Infect Dis. 2001;7:1-15.
92. Mody CH, Toews GB, Lipscomb MF. Cyclosporin A inhibits the growth of Cryptococcus neoformans in a murine model. Infect Immun. 1988;56:7-12.
93. De Vault GA, King JW, Rohr MS, et al. Opportunistic infections with Strongyloides stercoralis in renal transplantation. Rev Infect Dis. 1990;12:653-671.
94. Camargo LFA, Uip DE, Simpson AAG, et al. Comparison between antigenemia and a quantitative-competitive polymerase chain reaction for the diagnosis of cytomegalovirus infection after heart transplantation. Transplantation. 2001;71:412-417.
95. Gulati M, Kaur R, Jha V, et al. High-resolution CT in renal transplant patients with suspected pulmonary infections. Acta Radiol. 2000;41:237-241.
96. Torres A, Ewig S, Insausti J, et al. Etiology, and microbial patterns of pulmonary infiltrates in patients with orthotopic liver transplantation. Chest 2000;117:494-503.
97. Kollef MH, Ward S. The influence of mini-BAL cultures on pateint outcomes: implications for the antibiotic management of ventilator-associated pneumonia. Chest. 1998;113:412-420.
98. Luna CM, Vujacich P, Niederman MS, et al. Impact of BAL data on the therapy and outcome of ventilator-associated pneumonia. Chest. 1997;111:676-685.
99. Cazzadori A, Perri GD, Todeschini G, et al. Transbronchial biopsy in the diagnosis of pulmonary infiltrates in immunocompromised patients. Chest. 1995;107:101-106.
100. Ruiz LA, Gil P, Zalacain R, et al. Usefulness of bronchoalveolar lavage in the renal transplant patient with suspected respiratory infection. Arch Bronchopneumonia. 1998;34:388-393.
101. Wilcox PA, Bateman ED, Potgieter PD, et al. Experience with fiber-optic bronchoscopy in the diagnosis of pulmonary shadows in renal transplant recipients over a 12-year period. Respir Med. 1990;84:297-302.
102. Ellis ME, Spence D, Bouchama A, et al. Open lung biopsy provides a higher and more specific diagnostic yield compared to bronchoalveolar lavage in immunocompromised patients. Scand J Infect Dis. 1995;27:157-162.
103. Springemayer SC, Hackman RC, Holle R, et al. Use of bronchoalveolar lavage to diagnose acute diffuse pneumonia in the immunocompromised host. J Infect Dis. 1986;154:604-610.
104. Slavin MA, Gooley TA, Raleigh RA. Prediction of Cytomegalovirus pneumonia after marrow transplantation from cellular characteristics and Cytomegalovirus culture of bronchoalveolar lavage fluid. Transplantation. 1994;58:915-919.
105. Lloveras JJ, Lecuyer L, Didier A, et al. Benefits of bronchoscopy and bronchoalveolar lavage in the diagnosis of pneumonitis in transplant patients. Transplant Proc. 1993;25:2293.
106. Gleaves CA, Smith TF, Shuster EA, et al. Comparison of standard tube and shell vial cell culture techniques for the detection of cytomegalovirus in clinical specimens. J Clin Microbiol. 1985;21:217-221.
107. Cockerill FR, Wilson WR, Carpenter HA, et al. Open lung biopsy in immunocompromised patients. Arch Intern Med. 1985;145:1398-1404.
108. Kahn FE, Jones JM, England DM. The role of bronchoalveolar lavage in the diagnosis of invasive pulmonary Aspergillosis. Am J Clin Pathol. 1986;86:518-523.
109. Schulman LL, Smith CR, Drusin R, et al. Utility of airway endoscopy in the diagnosis of respiratory complications of cardiac transplantation. Chest. 1988;93:960-966.
110. Springmeyer SC, Silvestri RC, Sale GE. The role of transbronchial biopsy for the diagnosis of diffuse pneumonias in immunocompromised marrow transplant recipients. Am Rev Respir Dis. 1982;126:763-765.
111. Walker WA, Cole FH Jr, Khandekar A, et al. Does open lung biopsy affect treatment in patients with diffuse pulmonary infiltrates? J Thorac Cardiovasc Surg. 1989;97:534-540.
112. Cheson BD, Samlowski WE, Tang TT, et al. Value of open-lung biopsy in 87 immunocompromised patients with pulmonary infiltrates. Cancer. 1985;55:453-459.
113. Chaparro C, Maurer JR, Chamberlain DW, et al. Role of open lung biopsy for diagnosis in lung transplant recipients: ten-year experience. Ann Thorac Surg. 1995;59:928-932.
114. Haverkos H, Dowling JN, Pasculle AW, et al. Diagnosis of pneumonitis in immunocompromised patients by open lung biopsy. Cancer. 1983;52:1093-1097.
115. Crawford SW, Hackman RC, Clark J. Biopsy diagnosis and clinical outcome of persistent focal pulmonary lesions after marrow transplantation. Transplantation. 1989;48:266-271.